Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)
CUSIP: 45258J102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 202,731,676
- Total 13F shares
- 74,718,656
- Share change
- +4,424,494
- Total reported value
- $1,972,484,501
- Put/Call ratio
- 91%
- Price per share
- $26.40
- Number of holders
- 195
- Value change
- +$94,283,095
- Number of buys
- 103
- Number of sells
- 100
Quarterly Holders Quick Answers
What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258J102:
Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.8%
|
7,655,945
|
$247,363,595 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
6,478,304
|
$209,314,002 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
4,476,800
|
$144,645,407 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
3,641,907
|
$117,670,015 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
2,963,212
|
$95,741,380 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.1%
|
2,164,000
|
$69,918,840 | — | 31 Mar 2024 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.93%
|
1,882,704
|
$60,830,166 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.92%
|
1,862,043
|
$60,163,000 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.89%
|
1,809,172
|
$58,454,347 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.88%
|
1,775,000
|
$57,350,250 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.68%
|
1,383,810
|
$44,710,901 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
1,316,827
|
$42,552,912 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.64%
|
1,289,504
|
$41,663,874 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,271,762
|
$41,090,630 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.62%
|
1,265,298
|
$40,881,778 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.57%
|
1,150,123
|
$37,160,474 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.54%
|
1,104,278
|
$35,680,367 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.48%
|
976,237
|
$31,542,217 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
0.48%
|
969,621
|
$31,328,455 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
937,961
|
$30,305,521 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.43%
|
869,216
|
$28,084,369 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.41%
|
825,000
|
$26,655,750 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.39%
|
799,054
|
$25,817,435 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.37%
|
750,990
|
$24,264,487 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.32%
|
656,100
|
$21,198,591 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.31%
|
629,882
|
$20,351,000 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.31%
|
627,228
|
$20,265,737 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.29%
|
582,721
|
$18,827,716 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
573,447
|
$18,528,072 | — | 31 Mar 2024 | |
| Two Seas Capital LP |
13F
|
Company |
0.27%
|
541,295
|
$17,489,241 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
526,233
|
$17,002,588 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.25%
|
512,893
|
$16,571,573 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.25%
|
505,000
|
$16,316,550 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.24%
|
493,352
|
$15,940,203 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
478,707
|
$15,467,024 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.23%
|
472,540
|
$15,267,767 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
459,027
|
$14,831,162 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
442,084
|
$14,283,734 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.21%
|
425,009
|
$13,732,041 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
407,654
|
$13,171,300 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
349,177
|
$11,281,909 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
339,700
|
$10,976,000 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.16%
|
319,001
|
$10,306,923 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.15%
|
302,789
|
$9,783,113 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.14%
|
289,385
|
$9,350,029 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.14%
|
285,000
|
$9,208,350 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.14%
|
276,925
|
$8,947,446 | — | 31 Mar 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.14%
|
277,022
|
$8,928,696 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.13%
|
273,289
|
$8,829,968 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.13%
|
264,650
|
$8,550,842 | — | 31 Mar 2024 |
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2024
As of 30 Jun 2024,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,718,656 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., ARMISTICE CAPITAL, LLC, Deep Track Capital, LP, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, PERCEPTIVE ADVISORS LLC, Alpine Global Management, LLC, and Woodline Partners LP.
This page lists
195
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
208
Q2 2024 holders
195
Holder diff
-13
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.